Candidate Selection Before CMC to
Avoid Stability Risk
GenScript Probio provides professional Developability Assessment services for biologics. In the stage of antibody drug discovery and development, the early developability assessment services can evaluate the antibody and protein molecules to identify the potential risks of manufacture and clinical failure.
Developability Assessment is one of the most important evaluation in the development of biologics, which is bridging the drug discovery and CMC.
Two scenarios are involved in Developability Assessment. For both scenarios, GenScript Probio’s service can identify the potential developability risk and help to select the CMC candidates.
Capillary Electrophoresis System
Imaged Capillary Electrophoresis System
Developability assessment help to identify the potential developability risk and help to select the CMC candidates. Candidate C was chosen and finally succeed in CMC.